Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing

Japanese Circulation Journal

Volumn 62, Issue 4, 1998, Pages 267-273

  Naitoh, Naoki ^a   Washizuka, Takashi ^a   Takahashi, Kazuyoshi ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Antiarrhythmic drug; Block cycle length; Ventricular tachycardia; Zone of entrainment

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; AMIODARONE; ANTIARRHYTHMIC AGENT; NIFEKALANT; PROCAINAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART PACING; HEART VENTRICLE CONDUCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; REENTRY ARRHYTHMIA;

ADOLESCENT; ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CHILD; ELECTROPHYSIOLOGY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; PYRIDINES; PYRIMIDINONES; TACHYCARDIA, VENTRICULAR;

EID: 0031891067     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.267     Document Type: Article

References (30)

1. Waldo AL, Henthorn RW, Plumb VJ, Maclean MAH: Demonstration of the mechanism of transient entrapment and interruption of ventricular tachycardia with rapid atrial pacing. J Am Coll Cardiol 1984; 3: 422-430
2. Brugada P, Wellense HJJ: Entrainment as an electrophysiologic phenomenon. J Am Coll Cardiol 1984; 2: 451-454
3. Okumura K, Henthron RW, Epstein AE, Plumb VJ, Waldo AL: Further observation on transient entrainment. Importance of pacing site and properties of the components of the re-entrant circuit. Circulation 1985; 72: 1293-1307
4. Aizawa Y, Chinushi M, Naitoh N, Kusano Y, Shibata A: Entrainment of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. PACE 1991; 14: 1606-1613
5. Almendral JM, Stamato NJ, Rosenthal ME, Marchlinski FE, Miller JM, Josepbson ME: Resetting response during sustained ventricular tachycardia. Relationship to the excitable gap. Circulation 1986; 74: 722-730
6. Kay GN, Epstein AE, Plumb VJ: Incidence of reentry with an excitable gap in ventricular tachycardia. A prospective evaluation utilizing transient entrainment. J Am Coll Cardiol 1988; 11: 530-538
7. Kay GN, Epstein AE, Plumb VJ: Region of slow conduction in sustained ventricular tachycardia. Direct endocardial recordings and functional characterization in humans. J Am Coll Cardiol 1988; 11: 109-116
8. Aizawa Y, Niwano S, Chinushi M, Tamura M, Kusano Y, Miyajima T, et al: Incidence and mechanism of interruption of reentrant ventricular tachycardia with rapid ventricular pacing. Circulation 1992; 85: 589-595
9. Aizawa Y, Naitoh N, Kitazawa H, Kusano Y, Uchiyama H, Washizuka T, et al: Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease. Am J Cardiol 1993; 72: 916-921
10. Josephson ME: Evaluation of antiarrhythmic agents. In clinical cardiac electrophysiology: Techniques and interpretations, In: Josephson ME, editors. London: Lea & Febiger, 1993; 630-682
11. Aizawa Y, Naitoh N, Washizuka T, Kitazawa H, Takahashi K, Kodama I, et al: Procainamide-induced change in reentrant ventricular tachycardia with special reference to the tachycardiainterrupting critical paced cycle length during transient entrainment with rapid pacing. Jpn Heart J 1994; 35: 611-623
12. Aizawa Y, Chinushi M, Naitoh N, and Shibata A: Drug-induced narrowing of the width of the zone of entrainment as a predictor of subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug. Br Heart J 1996; 75: 165-170
13. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The Sicilian Gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991; 84: 1831-1851
14. Mason JW, Hondeghem LM, Katzung BG: Block of inactivated sodium channels and of depolarization induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 1984; 55: 277-285
15. Morady F, DiCargo Jr LA, Baerman JM, Krol RB: Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction. J Am Coll Cardiol 1985; 6: 179-185
16. Anderson KP, Walker R, Dustman T, Lux RL, Ershler PR, Kates RE, et al: Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo. Circulation 1989; 79: 948-958
17. Hondeghem LM. Snyders DJ: Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use dependence. Circulation 1990; 81: 686-692
18. Katoh H, Ogawa S, Furuno I. Sato Y, Yoh S, Saeki K, et al: Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on reentrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model. J Pharmacol Exp Ther 1990; 253: 1077-1082
19. Colatsky TJ, Follmer CH, Starmer CF: Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 1990; 82: 2235-2242
20. Inoue H, Yamashita T, Nozaki A, Sugimoto T: Effects of antiarrhythmic drugs on canine atrial flutter due to reentry. Relation of prolongation of refractory period and depression of conduction to excitable gap. J Am Coll Cardiol 1991; 18: 1098-1104
21. Giles WR. Imaizumi Y: Comparison of potassium currents in rabbit atrial and ventricular cells. J Physiol 1988; 405: 123-146
22. Hondeghem LM, Katzung BG: Time-and voltage-dependent interruptions of antiarrhythmic drugs with sodium channels. Biochim Biophys Acta 1977; 472: 373-398
23. Denes P, Wu D, Dhingra R, Pietras R, Rosen KM: The effects of cycle length on cardiac refractory periods in man. Circulation 1974; 45: 32-41
24. Morady F, Kadish AH, Toivonen LK, Kushner EA, Schmaltz S: The maximum effect of increase in rate on human ventricular refractoriness. PACE 1988; 11: 2223-2234
25. Cambell TJ: Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea pig ventricle and provide a theoretical basis for their subclassification. Cardiovasc Res 1983; 17: 344-352
26. Kay GNU, Epstein AE, Plumb VJ: Preferential effect of procainamide on the reentrant circuit of ventricular tachycardia. J Am Coll Cardiol 1989; 14: 382-390
27. Kay GN, Epstein AE, Plumb VJ: Region of slow conduction in sustained ventricular tachycardia: direct endocardial recordings and functional characterization in humans. J Am Coll Cardiol 1988; 109: 109-116
28. Stevenson WG, Weiss JN, Wiener I, Nademanee K, Wohlgelernter D, Yeatman L, et al: Resetting of ventricular tachycardia. Implications for localizing the area of slow conduction. J Am Coll Cardiol 1988; 11: 522-529
29. Aizawa Y, Abe A, Ohira K, Furushima H, Chinushi M, Fujita S: Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia. J Am Coll Cardiol 1996; 28: 1759-1764
30. Kay GN, Epstein AF, Plumb VJ: Resetting of ventricular tachycardia by single extrastimuli. Relation to slow conduction within the reentrant circuit. Circulation 1990; 81: 1507-1519